Solve Your Your Legal Issues, now offering Affordable and Flat Fee Pricing options

  • Home
  • About
  • Contact Us
  • Current Legal Issues
  • Copyright
  • Patent
  • TMT Intelligence
  • Patent Flyer
  • More
    • Home
    • About
    • Contact Us
    • Current Legal Issues
    • Copyright
    • Patent
    • TMT Intelligence
    • Patent Flyer
  • Home
  • About
  • Contact Us
  • Current Legal Issues
  • Copyright
  • Patent
  • TMT Intelligence
  • Patent Flyer

Current IP Legal Issues to Watch

Digital scales of justice symbol glowing in a futuristic blue and purple tech design.

Biotech/ PhRMA: Congressional Patent Hearing

The U.S. House Judiciary IP Subcommittee to hold a hearing on patents, drug prices, and affordability, the week of June 2, 2026.


Watch the hearing and download witness testimony here:

https://judiciary.house.gov/schedule

 

Biotech/ PhRMA: Supreme Court to review "Skinny Labels"

Hikma Pharmaceuticals USA v. Amarin Pharma, Inc. et al.

SCOTUSBlog coverage

https://www.scotusblog.com/2026/04/justices-poised-to-protect-generics-manufacturers-from-liability-for-decisions-of-pharmacists-ab/


Supreme Court Oral Argument Transcript

https://www.supremecourt.gov/oral_arguments/argument_transcripts/2025/24-889_2024.pdf

Biotech/ PhRMA: Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc

 Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)

https://www.cafc.uscourts.gov/opinions-orders/24-1641.OPINION.5-13-2026_2693032.pdf    "

###

### 

"XXXX"

Other Washington, D.C. Legal Resources

GAO Report on Nonprofit Drug Companies

Nonprofit Drug Companies: Information on Funding, Drug Types, Challenges, and Reported Effect
GAO-25-107153
Published: May 01, 2025. Publicly Released: May 01, 2025.

https://www.gao.gov/products/gao-25-107153

U.S. Senate Patent Eligibility Hearing

The Senate Subcommittee on Intellectual Property held a key hearing regarding the Patent Eligibility Restoration Act (PERA) on October 8, 2025. 

  • The bipartisan legislation seeks to reform 35 U.S.C. § 101 to effectively overturn Supreme Court decisions that restricted patent eligibility for abstract ideas, isolated genetic materials, and diagnostic methods. 


  • Watch the hearing here:
  • https://www.judiciary.senate.gov/committee-activity/hearings/the-patent-eligibility-restoration-act_restoring-clarity-certainty-and-predictability-to-the-us-patent-system-10-08-2025

AI/ Digital Replicas

The U.S. Congress is pursuing legislation to fight unauthorized Gen AI digital replicas.  It's called the "NO FAKES Act."  More below.


U.S. Senate Press release

https://www.google.com/search?client=safari&rls=en&q=blackburn+no+fakes&ie=UTF-8&oe=UTF-8


Updated Bill Text

https://www.blackburn.senate.gov/services/files/7B628752-82C4-4FC6-89DC-94345BC06540



Copyright © 2026 Association Counsel Law Firm - All Rights Reserved.

Powered by

  • Home